India, Oct. 19 -- Drug major Johnson & Johnson (JNJ) announced Monday positive one-year results from the Phase 3 FUZION study, which showed TREMFYA (guselkumab) maintained or improved fistula remissio... Read More
India, Oct. 19 -- IDEAYA Biosciences Inc. (IDYA), a precision medicine oncology company, on Monday released updated clinical data on three trials evaluating Darovasertib in treating metastatic and pri... Read More
India, Oct. 19 -- The investors are responding to Iran's threat for another round of war with the US and its allies on Monday. Initial signs from the U.S. Futures Index suggest that Wall Street might... Read More
India, Oct. 19 -- Canadian stocks are seen opening on a mixed note Monday morning, tracking mixed trend in commodity prices and weak European markets. Firm Nasdaq futures point to some strong buying i... Read More
India, Oct. 19 -- Fifth Third Bancorp (FITB) will host a conference call at 9:00 AM ET on October 19, 2026, to discuss Q3 26 earnings results. To access the live webcast, log on to https://ir.53.com/... Read More
India, Oct. 19 -- U.K. stocks shed ground on Monday, tracking weakness in other European markets amid rising tensions due to civil unrest in several countries across the continent. Worries about Russi... Read More
India, Oct. 19 -- Cleveland-Cliffs Inc. (CLF) will host a conference call at 8:30 AM ET on October 19, 2026, to discuss Q3 26 earnings results. To access the live webcast, log on to https://www.cleve... Read More
India, Oct. 19 -- Fifth Third Bancorp (FITB), a regional bank, reported Monday higher profit and net interest and Noninterest income in the third quarter, as the company continued integrating Comerica... Read More
India, Oct. 19 -- Growing civil unrest in France and tensions elsewhere in Europe, along with cocerns over Middle East tensions hurt French stocks on Monday. The benchmark CAC 40 dropped nearly 1.5% a... Read More
India, Oct. 19 -- Japan's Takeda Pharmaceutical Co. Ltd. (TAK,4502.T) announced Monday positive new data from VERDICT (NCT04259138), a Phase 4 ENTYVIO clinical trial, in ulcerative colitis or UC-relat... Read More